Natixis’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,234,713
| Closed | -$222M | – | 1026 |
|
|
2019
Q3 | $222M | Buy |
2,234,713
+1,400,844
| +168% | +$133M | 1.43% | 12 |
|
|
2019
Q2 | $77.1M | Buy |
833,869
+629,327
| +308% | +$59.8M | 0.59% | 37 |
|
|
2019
Q1 | $19.3M | Sell |
204,542
-210,245
| -51% | -$18.4M | 0.12% | 171 |
|
|
2018
Q4 | $26.6M | Buy |
414,787
+53,359
| +15% | +$3.94M | 0.22% | 118 |
|
|
2018
Q3 | $32.3M | Sell |
361,428
-391,601
| -52% | -$34.6M | 0.19% | 126 |
|
|
2018
Q2 | $59.8M | Sell |
753,029
-993,387
| -57% | -$82.5M | 0.32% | 87 |
|
|
2018
Q1 | $156M | Buy |
1,746,416
+1,241,120
| +246% | +$119M | 0.96% | 19 |
|
|
2017
Q4 | $52.7M | Buy |
505,296
+340,074
| +206% | +$38.4M | 0.41% | 67 |
|
|
2017
Q3 | $24.1M | Buy |
165,222
+161,530
| +4,375% | +$22M | 0.22% | 113 |
|
|
2017
Q2 | $479K | Sell |
3,692
-215,254
| -98% | -$26.4M | 0.01% | 529 |
|
|
2017
Q1 | $27.2M | Sell |
218,946
-44,400
| -17% | -$5.31M | 0.34% | 79 |
|
|
2016
Q4 | $30.5M | Buy |
+263,346
| New | +$29.3M | 0.31% | 82 |
|
|
2016
Q3 | – | Sell |
-187,894
| Closed | -$18.5M | – | 595 |
|
|
2016
Q2 | $18.5M | Buy |
187,894
+131,724
| +235% | +$13.6M | 0.34% | 68 |
|
|
2016
Q1 | $5.62M | Buy |
+56,170
| New | +$5.78M | 0.09% | 140 |
|
|
2015
Q2 | – | Sell |
-4,922
| Closed | -$567K | – | 478 |
|
|
2015
Q1 | $567K | Sell |
4,922
-13,924
| -74% | -$1.66M | 0.01% | 291 |
|
|
2014
Q4 | $2.11M | Buy |
+18,846
| New | +$1.99M | 0.03% | 172 |
|
|
2014
Q3 | – | Sell |
-257,690
| Closed | -$22.1M | – | 524 |
|
|
2014
Q2 | $22.1M | Sell |
257,690
-499,480
| -66% | -$38M | 0.27% | 90 |
|
|
2014
Q1 | $52.9M | Buy |
757,170
+390,316
| +106% | +$30.9M | 0.69% | 33 |
|
|
2013
Q4 | $31M | Sell |
366,854
-248,546
| -40% | -$19.7M | 0.27% | 82 |
|
|
2013
Q3 | $47.4M | Sell |
615,400
-104,610
| -15% | -$7.33M | 0.51% | 53 |
|
|
2013
Q2 | $42.1M | Buy |
+720,010
| New | +$43.3M | 0.6% | 40 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Natixis's CELG Position: Q4 2019 in Review
Natixis sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,234,713 shares — an estimated $222M sold.
Natixis first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $222M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Natixis reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Natixis sold 2,234,713 Celgene Corp shares in Q4 2019, an estimated $222M.
- Natixis first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
- Natixis's Celgene Corp position peaked at $222M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Natixis's 13F filing for Q4 2019, filed 14 Feb 2020.